Medications

Milvexian shows potential to reduce risk of ischemic stroke

A phase 2 trial in patients with a prior ischemic stroke or high-risk transient ischemic attack (TIA) has indicated that milvexian should be further investigated for its ability to reduce the risk of ischemic stroke without ...

Cardiology

Rates of VTE, major bleeding high in primary CNS lymphoma

(HealthDay)—For patients with primary central nervous system lymphoma (PCNSL), the incidence of venous thromboembolism (VTE) and major bleeding is high, according to a study published in the November issue of Leukemia & ...

Oncology & Cancer

Incidence of VTE, major bleeding high in primary CNS lymphoma

(HealthDay)—The incidence of venous thromboembolism (VTE) and major bleeding is high among patients with primary central nervous system lymphoma (PCNSL), according to a study published online June 23 in Leukemia & Lymphoma.

Medications

Safety, effectiveness of VKAs, DOACs similar in general practice

(HealthDay)—For patients receiving anticoagulants, arteriovenous events and major bleeding events do not differ for those receiving vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs), according to a study ...

Cardiology

Study compares anticoagulants for antiphospholipid syndrome

(HealthDay)—In thrombotic antiphospholipid antibody syndrome (APS), rivaroxaban is not noninferior to dose-adjusted vitamin K antagonists (VKAs), according to a study published online Oct. 15 in the Annals of Internal Medicine.

Cardiology

Combo antithrombotic therapy increases bleeding risk

(HealthDay)—Patients with chronic coronary artery disease or peripheral artery disease treated with the combination of rivaroxaban and aspirin face a greater risk for bleeding versus patients treated with aspirin alone, ...

Medications

History of liver disease does not impact efficacy of edoxaban

(HealthDay)—For patients with atrial fibrillation (AF), the efficacy and safety of edoxaban versus warfarin is not altered with a history of liver disease, according to a study published in the July 16 issue of the Journal ...

page 2 from 9